New heart device could cut stroke risk for millions unable to take blood thinners
Disease control
Ongoing
This study is testing a device called the Omega LAA Occluder, which is placed in the heart to close off a small pouch (the left atrial appendage) where blood clots can form in people with atrial fibrillation. The goal is to reduce the risk of stroke without needing long-term bloo…
Phase: NA • Sponsor: Eclipse Medical Ltd. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC